Literature DB >> 30148454

Neutralize the neutrophils! Neutrophil β1/β2 integrin activation contributes to JAK2-V617F-driven thrombosis.

Stephen T Oh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30148454      PMCID： PMC6159984          DOI： 10.1172/JCI123388

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  16 in total

Review 1.  Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasms.

Authors:  Brady L Stein; Jason Gotlib; Murat Arcasoy; Marie Huong Nguyen; Neil Shah; Alison Moliterno; Catriona Jamieson; Daniel A Pollyea; Bart Scott; Martha Wadleigh; Ross Levine; Rami Komrokji; Rebecca Klisovic; Krishna Gundabolu; Patricia Kropf; Meir Wetzler; Stephen T Oh; Raul Ribeiro; Rita Paschal; Sanjay Mohan; Nikolai Podoltsev; Josef Prchal; Moshe Talpaz; David Snyder; Srdan Verstovsek; Ruben A Mesa
Journal:  J Natl Compr Canc Netw       Date:  2015-04       Impact factor: 11.908

Review 2.  Leukocyte Anti-Trafficking Strategies: Current Status and Future Directions.

Authors:  Bruce E Sands
Journal:  Dig Dis       Date:  2017-02-01       Impact factor: 2.404

3.  Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?

Authors:  Tiziano Barbui; Alessandra Carobbio; Alessandro Rambaldi; Guido Finazzi
Journal:  Blood       Date:  2009-04-16       Impact factor: 22.113

Review 4.  Thrombosis in Philadelphia negative classical myeloproliferative neoplasms: a narrative review on epidemiology, risk assessment, and pathophysiologic mechanisms.

Authors:  Somedeb Ball; Kyaw Zin Thein; Abhishek Maiti; Kenneth Nugent
Journal:  J Thromb Thrombolysis       Date:  2018-05       Impact factor: 2.300

5.  White blood cell counts and thrombosis in polycythemia vera: a subanalysis of the CYTO-PV study.

Authors:  Tiziano Barbui; Arianna Masciulli; Maria Rosa Marfisi; Giovanni Tognoni; Guido Finazzi; Alessandro Rambaldi; Alessandro Vannucchi
Journal:  Blood       Date:  2015-07-23       Impact factor: 22.113

6.  JAK2-V617F promotes venous thrombosis through β1/β2 integrin activation.

Authors:  Bärbel Edelmann; Nibedita Gupta; Tina M Schnoeder; Anja M Oelschlegel; Khurrum Shahzad; Jürgen Goldschmidt; Lars Philipsen; Soenke Weinert; Aniket Ghosh; Felix C Saalfeld; Subbaiah Chary Nimmagadda; Peter Müller; Rüdiger Braun-Dullaeus; Juliane Mohr; Denise Wolleschak; Stefanie Kliche; Holger Amthauer; Florian H Heidel; Burkhart Schraven; Berend Isermann; Andreas J Müller; Thomas Fischer
Journal:  J Clin Invest       Date:  2018-07-19       Impact factor: 14.808

7.  Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia.

Authors:  Valerio De Stefano; Tommaso Za; Elena Rossi; Alessandro M Vannucchi; Marco Ruggeri; Elena Elli; Caterina Micò; Alessia Tieghi; Rossella R Cacciola; Cristina Santoro; Giancarla Gerli; Paola Guglielmelli; Lisa Pieri; Francesca Scognamiglio; Francesco Rodeghiero; Enrico M Pogliani; Guido Finazzi; Luigi Gugliotta; Giuseppe Leone; Tiziano Barbui
Journal:  Am J Hematol       Date:  2010-02       Impact factor: 10.047

8.  Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms: A Population-Based Cohort Study.

Authors:  Malin Hultcrantz; Magnus Björkholm; Paul W Dickman; Ola Landgren; Åsa R Derolf; Sigurdur Y Kristinsson; Therese M L Andersson
Journal:  Ann Intern Med       Date:  2018-01-16       Impact factor: 25.391

Review 9.  Thrombosis in myeloproliferative disorders: prevalence, prognostic factors, and the role of leukocytes and JAK2V617F.

Authors:  Ayalew Tefferi; Michelle Elliott
Journal:  Semin Thromb Hemost       Date:  2007-06       Impact factor: 4.180

10.  NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018.

Authors:  Ruben A Mesa; Catriona Jamieson; Ravi Bhatia; Michael W Deininger; Christopher D Fletcher; Aaron T Gerds; Ivana Gojo; Jason Gotlib; Krishna Gundabolu; Gabriela Hobbs; Brandon McMahon; Sanjay R Mohan; Stephen Oh; Eric Padron; Nikolaos Papadantonakis; Philip Pancari; Nikolai Podoltsev; Raajit Rampal; Erik Ranheim; Vishnu Reddy; Lindsay A M Rein; Bart Scott; David S Snyder; Brady L Stein; Moshe Talpaz; Srdan Verstovsek; Martha Wadleigh; Eunice S Wang; Mary Anne Bergman; Kristina M Gregory; Hema Sundar
Journal:  J Natl Compr Canc Netw       Date:  2017-10       Impact factor: 11.908
View more
  2 in total

Review 1.  Neutrophil Death in Myeloproliferative Neoplasms: Shedding More Light on Neutrophils as a Pathogenic Link to Chronic Inflammation.

Authors:  Dragana Marković; Irina Maslovarić; Dragoslava Djikić; Vladan P Čokić
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 5.923

Review 2.  JAK2 Variant Signaling: Genetic, Hematologic and Immune Implication in Chronic Myeloproliferative Neoplasms.

Authors:  Dania G Torres; Jhemerson Paes; Allyson G da Costa; Adriana Malheiro; George V Silva; Lucivana P de Souza Mourão; Andréa M Tarragô
Journal:  Biomolecules       Date:  2022-02-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.